Drug Approval Package

Keppra XR (Levetiracetam) Extended-Release Tablets
Company: UCB Inc.
Application No.:  022285
Approval Date: 09/12/2008

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

Approval Letter(s) (PDF) 

• Summary Review (PDF) 

• Officer/Employee List (PDF) 

• Cross Disipline Team Leader Review (PDF) 

• Printed Labeling (PDF) 

• Medical Review(s) (PDF) 

• Chemistry Review(s) (PDF) 

• Pharmacology Review(s) (PDF) 

• Statistical Review(s) (PDF) 

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF) 

• Risk Assessment and Risk Mitigation Review(s) (PDF) 

• Proprietary Name Review(s) (PDF) 

• Administrative Document(s) & Correspondence (PDF) 

Date created: January 5, 2009

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.